Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial

BACKGROUND: Patients with chronic coronary artery disease or peripheral artery disease and history of heart failure (HF) are at high risk for major adverse cardiovascular events. We explored the effects of rivaroxaban with or without aspirin in these patients. METHODS: The COMPASS trial (Cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Branch, Kelley R., Probstfield, Jeffrey L., Eikelboom, John W., Bosch, Jackie, Maggioni, Aldo P., Cheng, Richard K., Bhatt, Deepak L., Avezum, Alvaro, Fox, Keith A.A., Connolly, Stuart J., Shestakovska, Olga, Yusuf, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693980/
https://www.ncbi.nlm.nih.gov/pubmed/31163978
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.039609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693980/
https://www.ncbi.nlm.nih.gov/pubmed/31163978
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.039609

Ejemplares similares